SINGAPORE, June 09, 2026 (GLOBE NEWSWIRE) — Vocalbeats.AI, a Singapore-based AI-powered audio company, today announces its Gold Sponsorship of SuperAI 2026, taking place on 10–11 June 2026 at Marina Bay Sands, Singapore.
As part of its Gold Sponsorship, Vocalbeats.AI will sponsor continental breakfast, lunch and afternoon tea sessions on Day 1, with branded signage in the Food & Beverage (F&B) area and the corporate logo displayed across the venue, event stages and website.
SuperAI convenes more than 10,000 founders, investors, and enterprise leaders to explore the frontiers of AI — spanning large language models (LLMs), agentic systems, voice AI, and AI infrastructure.
Vocalbeats.AI’s focus on voice AI, real-time multimodal interaction, and practical consumer AI applications places it squarely within these themes. Its flagship applications, Owll, a voice-first productivity app, and Owll Translator, a real-time multilingual translation app, reflect that focus in everyday use across global markets. As AI development moves increasingly from capability to usability — how AI becomes integrated into communication, productivity, and daily life at scale, the company sees SuperAI as a timely platform to engage with the broader industry on that shift.
The sponsorship also reflects Vocalbeats.AI’s deepening presence in Singapore’s AI ecosystem. Earlier this year, the company established two university scholarship programmes — the Vocalbeats.AI–Turing AI Scholarship with Nanyang Technological University, Singapore (NTU Singapore) and the Vocalbeats.AI Scholarship at the National University of Singapore (NUS). Both initiatives provide recipients with access to career pathways at Vocalbeats.AI, reflecting the company’s commitment to nurturing Singapore’s next generation of AI talent.
About Vocalbeats.AI
Vocalbeats.AI is a Singapore-based AI-powered audio company dedicated to innovating intelligent, user-friendly products and services designed to improve everyday life with more lifelike, intuitive, and accessible voice AI. Its expanding portfolio of AI-powered applications—spanning productivity, wellness, and beyond—is increasingly being embraced by a diverse global user base.
Beyond developing applications, Vocalbeats.AI is redefining how people interact with AI. Powered by an international team of engineers, designers and researchers, the Company pushes the boundaries of voice and AI technology to empower people everywhere to work smarter, connect more meaningfully, and live better.
For more information, please visit http://www.vocalbeats.ai.
Media contact: media@vocalbeats.com
About Web3Wire Web3Wire – Information, news, press releases, events and research articles about Web3, Metaverse, Blockchain, Artificial Intelligence, Cryptocurrencies, Decentralized Finance, NFTs and Gaming. Visit Web3Wire for Web3 News and Events, Block3Wire for the latest Blockchain news and Meta3Wire to stay updated with Metaverse News.
The FIFA World Cup has become a multibillion-dollar trading event before its June 11 kickoff, with prediction-market traders nearly split on whether Spain or France should be treated as the team to beat in the tournament.
Polymarket data show Spain and France each trading near a 16% implied chance of winning the tournament, ahead of England at about 11%, Portugal at 10%, and defending champion Argentina at 9%.
Prices on Kalshi, a regulated US-trading venue, show a similar race at the top, with Spain near 16.5%, France at 16.2%, Portugal at 10.5%, England at 10.1%, and Argentina at 8.9%.
World Cup Bets on Polymarket (Source: Polymarket)
These numbers are not forecasts in the traditional sense, as they reflect where traders are willing to buy and sell event contracts that pay out if a team wins the tournament.
Still, the size of the market has turned the 2026 FIFA World Cup into an early test of whether prediction platforms can compete with sportsbooks during one of the most-watched sporting events in the world.
Already, Polymarket’s World Cup winner market has generated roughly $2 billion in trading volume before the tournament begins, while Kalshi’s comparable market has crossed $100 million.
The figures place the event among the largest sports markets yet for prediction platforms, whose rapid growth has pushed them into territory long dominated by licensed gambling operators.
World Cup gives platforms their largest sports test
For Polymarket and Kalshi, the World Cup arrives at a pivotal moment.
The 2026 tournament is the first men’s World Cup since prediction markets moved beyond their earlier base in crypto, politics, and macroeconomic events into mainstream sports speculation.
The event gives the sector its largest sports test yet, with a global audience, 48 teams, 104 matches, and weeks of shifting narratives that can be turned into tradable contracts.
Historically, sportsbooks have always given fans a way to wager on teams and players. Prediction markets are newer and add a structure closer to financial trading, where users can enter, exit, trim, or increase positions before an event is resolved.
In simple terms, prediction markets allow users to buy and sell contracts tied to future events. A contract trading at 40 cents implies a 40% market-implied probability and pays $1 if the outcome occurs.
This means the prices can move as traders react to injuries, team news, match results, tactical changes, and other developments.
That flexibility is central to the surge in World Cup activity.
A trader who buys Spain before the opening match does not have to hold the position until the final in July. If Spain wins its group comfortably or receives a favorable knockout draw, the contract price could rise and allow the trader to sell before the tournament ends. If a key player is injured or the team faces a more difficult path, the position can be reduced before it settles at zero.
The same logic applies to France, Portugal, England, and Argentina, whose prices remain close enough to keep the market competitive. France’s squad depth, Spain’s recent form, England’s attack, Portugal’s Nations League momentum, and Argentina’s status as defending champion have all given traders competing cases to price.
That has helped turn the winner market into a live trading venue rather than a static pre-tournament betting board. Prices can adjust after each match, press conference, injury update, or disciplinary decision. The result is a tournament-long market that tracks changing sentiment as the field narrows.
However, that scale does not make the market immune to bias. Prediction markets can still reflect momentum, public attention, fan loyalty, and uneven access to information.
For context, a national team with a large global following may draw more trading interest than a less popular side with a similar chance of winning. Traders can also overreact to short-term developments in a tournament where one injury, suspension, or red card can reshape the path to the final.
Still, the activity shows how sports have become a major growth channel for event-contract platforms.
Pew Research Center found that combined monthly global trading volume on Kalshi and Polymarket rose from less than $5 billion in September 2025 to about $24 billion in April 2026. That compares with about $14 billion in average monthly legal sportsbook wagers in the US last year.
Sports have been especially important for Kalshi, where they have accounted for the bulk of trading volume since the platform expanded beyond politics and macroeconomic events. Polymarket’s activity is spread more broadly across sports, politics, and crypto, but the World Cup shows how a single global event can concentrate liquidity across one set of contracts.
In view of this, several crypto companies, including President Donald Trump-related firms, are now trying to tap into that demand.
CryptoSlate Daily Brief
Daily signals, zero noise.
Market-moving headlines and context delivered every morning in one tight read.
5-minute digest 100k+ readers
Free. No spam. Unsubscribe any time.
Whoops, looks like there was a problem. Please try again.
You’re subscribed. Welcome aboard.
Exchanges and wallet providers, including Bitget, OKX, and Gate, have introduced World Cup-related products or campaigns aimed at turning global attention into trading activity.
The push reflects a broader shift in crypto marketing, with firms increasingly attaching products to major cultural events rather than relying only on token prices or blockchain-specific narratives.
Alvin Kan, chief operating officer at Bitget Wallet, said prediction markets are becoming a new way for users to participate in global events. He stated:
“The World Cup shows why this matters: billions of people are not only watching the same moments, but forming views, debating outcomes and acting on conviction in real time.”
Regulators watch the line between trading and gambling
Meanwhile, the World Cup surge is landing as regulators, lawmakers, and state officials examine how far prediction markets should be allowed to expand.
Kalshi is regulated by the Commodity Futures Trading Commission (CFTC), while Polymarket’s main international exchange is not CFTC-regulated and has generally barred US users. Polymarket has also launched a US operation, though its international venue remains the larger marketplace.
The distinction has become central to the policy debate. Supporters say federally regulated event contracts can bring transparency, surveillance, and standardized market rules to a space that already exists through offshore sportsbooks and informal betting.
Critics say sports markets are gambling products by another name and could bypass state consumer-protection regimes if they are treated only as derivatives. In fact, several US states have argued that these prediction markets’ sports contracts amount to sports gambling and should be regulated by their local frameworks.
However, the CFTC has countered that these platform contracts fall within its regulatory jurisdiction.
Meanwhile, these concerns go beyond jurisdiction. As prediction markets grow, regulators are looking more closely at know-your-customer checks, market manipulation, insider information, fraud prevention, and data security.
Those risks become more visible when millions of users trade contracts tied to sports, politics, and other events with nonpublic information.
While sports contracts may avoid some of the insider-trading concerns that surround elections, they still carry information risks.
Team staff, medical personnel, agents, broadcasters, and others may know details about injuries, tactical changes, or player availability before the public does. Those details can move prices, especially in highly liquid markets tied to major teams.
In response, the platforms say they have surveillance tools and market-integrity systems to detect suspicious activity. Kalshi uses identity checks and monitoring programs. Polymarket has said it maintains a market-integrity framework and has referred suspicious wallets to law enforcement in prior cases.
The World Cup will test those systems at scale. A 39-day tournament with 104 matches gives traders a constant stream of new information and gives platforms repeated chances to show whether their markets can function through volatility, news shocks, and heavy retail participation.
Sam Bankman-Fried field an application for pardon with the Office of the Pardon Attorney.
He told Fox Business last week that he “absolutely” would take a pardon, though the process can take months or years.
The FTX co-founder and former CEO is currently serving a 25-year sentence for his crimes.
FTX founder and former CEO Sam Bankman-Fried (aka SBF) has formally applied for a presidential pardon according to an update on the Office of the Pardon Attorney website.
Bankman-Fried, who was convicted on fraud and conspiracy charges in 2024 and sentenced to 25 years in prison, is seeking a “pardon after completion of sentence” relief. The news was first reported by Bloomberg.
“It would be obviously, you know, ultimately up to the president, not up to me,” Bankman-Fried told Fox Business in a phone interview from prison last week, adding that he would “absolutely” accept a pardon from President Donald Trump.
The crypto entrepreneur told Fox Business that he has not personally spoken to anyone at the White House, while noting that he couldn’t speak for his parents, or others close to him, who may have.
The pending application may take “months or years,” according to the official application listed on the Office of the Pardon Attorney website. Because applications are not made public, details about his request are currently unknown.
Bankman-Fried maintained his innocence while speaking to Fox Business, and added that he “didn’t steal user funds either,” noting that customers were ultimately repaid in full via the bankruptcy process while calling it a “great disservice that it has taken three years.”
The imprisoned crypto fraudster has clamored for a pardon in a not-so-subtle manner at times this year.
In February, he drew the attention of both Democratic and Republican senators when his X account started championing the Clarity Act—a still-in-the-works crypto market structure bill. That led to a strong retort from Wyoming Senator Cynthia Lummis who said “someone’s looking for a pardon” while adding “we don’t need—nor want—your support.”
President Trump previously ruled out a pardon for SBF, but has granted pardons to prominent crypto personalities like Silk Road founder Ross Ulbricht, BitMex co-founder Arthur Hayes and his co-founders Benjamin Delo and Samuel Reed, and Binance co-founder Changpeng “CZ” Zhao.
Bankman-Fried, who has served a little more than two years for his crimes, is expected to serve at least 21.25 years of his sentence, according to analysts who spoke to Decrypt at the time of his sentencing.
A representative for the Office of Pardon Attorney confirmed to Decrypt that those applying for “pardon after completion of sentence” must finish their sentence first.
Daily Debrief Newsletter
Start every day with the top news stories right now, plus original features, a podcast, videos and more.
AUSTIN, Texas, June 08, 2026 (GLOBE NEWSWIRE) — Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) announced today that its 1st Detect TRACER 1000 system has received the European Civil Aviation Conference (“ECAC”) certification for wand swabbing, approved for use in screening both passengers and cargo in aviation security operations.
“Wand swabbing certification extends our TRACER 1000 customer base to include airports that require wand swabbing,” said Tom Pickens, Chairman and CEO of Astrotech Corporation. “We believe our technology allows for a less intrusive method of passenger testing, while also reducing bottlenecks, allowing airports to process more passengers without sacrificing security stringency.”
The certification covers the TRACER 1000 for wand-based sampling, enabling checkpoint operators to collect trace samples from passengers and cargo without direct contact. The system satisfies the ECAC Explosives Detection Standard and Standard G1 under Concept of Operations Revision 38. The TRACER 1000 is a field-proven mass spectrometry solution deployed in 16 countries worldwide, providing laboratory-grade molecular identification in environments where no-touch collection is operationally required.
About 1st Detect
Based in Austin, Texas, 1st Detect develops, manufactures, and sells trace detectors for security and detection markets. A subsidiary of Astrotech Corporation, the company’s TRACER 1000 ETD® and TRACER 1000 NTD™ systems deliver laboratory-grade performance in portable designs built for real-world environments.
For more information, visit https://1stdetect.com.
About Astrotech Corporation
Astrotech Corporation is an instrumentation company that that creates, operates, and scales innovative businesses through its wholly owned subsidiaries.
1st Detect develops, manufactures, and markets trace detection systems for explosives and narcotics.AgLAB designs process analyzers tailored to the processing of biomass essential oils.Pro-Control produces solutions using proprietary gas chromatography/mass spec chemical autonomous process control that is ideal for both the moon and earth.EN-SCAN, Inc. delivers portable, ruggedized environmental GC-MS for on-site testing of air, water and soil.
Astrotech is currently evaluating opportunities to identify, develop, and commercialize advanced technologies with applications in space, defense, industrial, and related markets.
Astrotech is headquartered in Austin, Texas. For more information, visit http://www.astrotechcorp.com.
Forward-Looking Statements
This press release contains “forward-looking statements” that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks, trends, and uncertainties that could cause actual results to be materially different from the forward-looking statement. These statements may be identified by terms such as “aims,” “anticipates,” “believes,” “contemplates,” “continue,” “could,” “estimates,” “expect,” “forecast,” “guidance,” “intends,” “may,” “plans,” “possible,” “potential,” “predicts,” “preliminary,” “projects,” “seeks,” “should,” “targets,” “will” or “would,” or the negatives of these terms, variations of these terms or other similar expressions. Forward-looking statements are based on current expectations, estimates, forecasts, and projections, as well as management’s current beliefs and assumptions, and are subject to risks, uncertainties, and other factors that could cause actual results to differ materially from those expressed or implied by such statements. These risks and uncertainties include, but are not limited to, the early-stage nature of the lunar initiative; technical, engineering, regulatory, financial, operational, market, and commercial risks; the availability and cost of lunar transportation and launch services; the Company’s ability to secure strategic partners, customers, government support, or financing; the uncertain timing and development of lunar resource markets; risks associated with autonomous lunar operations and advanced technology development; the adverse impact of inflationary pressures, including significant increases in fuel costs, global economic conditions and events related to these conditions, including the ongoing wars in Ukraine and the middle east, the Company’s use of proceeds from the common stock offerings, whether we can successfully complete the development of our new products and proprietary technologies, whether we can obtain the FDA and other regulatory approvals required to market our products under development in the United States or abroad, whether the market will accept our products and services and whether we are successful in identifying, completing and integrating acquisitions, as well as other risk factors and business considerations described in the Company’s Securities and Exchange Commission filings including the Company’s most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Any forward-looking statements in this document should be evaluated in light of these important risk factors. While we do not intend to directly harvest, manufacture, distribute or sell cannabis or cannabis products, we may be detrimentally affected by a change in enforcement by federal or state governments and we may be subject to additional risks in connection with the evolving regulatory area and associated uncertainties. Any such effects may give rise to risks and uncertainties that are currently unknown or amplify others mentioned herein. Although the Company believes the expectations reflected in its forward-looking statements are reasonable and are based on reasonable assumptions, no assurance can be given that these assumptions are accurate or that any of these expectations will be achieved (in full or at all) or will prove to have been correct. Moreover, such statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond the control of the Company, which may cause actual results to differ materially from those implied or expressed by the forward-looking statements. In addition, any forward-looking statements included in this press release represent the Company’s views only as of the date of its publication and should not be relied upon as representing its views as of any subsequent date. The Company assumes no obligation to correct or update these forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.
Company Contact: Scott Bartley, Interim Chief Financial Officer, Astrotech Corporation | (512) 485-9530
About Web3Wire Web3Wire – Information, news, press releases, events and research articles about Web3, Metaverse, Blockchain, Artificial Intelligence, Cryptocurrencies, Decentralized Finance, NFTs and Gaming. Visit Web3Wire for Web3 News and Events, Block3Wire for the latest Blockchain news and Meta3Wire to stay updated with Metaverse News.
HDV-Insulin Lispro (HDV-LIS) met A1C non-inferiority at Weeks 12 and 25, confirming comparable glycemic control to insulin lispro (LIS) with point-estimate differences below FDA-required 0.1% thresholdHDV-LIS achieved statistically significant reductions in continuous glucose monitoring (CGM)-measured hypoglycemia across multiple endpoints during the maintenance periodZero Level 3 (severe) hypoglycemic events with HDV-LIS vs. five with LISResults point to the potential of restoring mealtime liver insulin exposure to improve the balance between glycemic control and hypoglycemia risk. Nearly 2.1 million Americans live with type 1 diabetes1 and each year, approximately 20% will experience a severe hypoglycemia event.2,3Presented as an oral presentation at the American Diabetes Association (ADA) 86th Scientific Sessions
NEW ORLEANS, June 07, 2026 (GLOBE NEWSWIRE) — Diasome Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing portal-hepatic targeted therapies for metabolic disease, announced Phase 2b results from OPTI-2, a potentially groundbreaking 25-week, double-blind, randomized controlled trial comparing hepatocyte-directed vesicle insulin lispro (HDV-LIS) with standard insulin lispro (LIS) in 226 adults with type 1 diabetes. In an oral presentation today at the American Diabetes Association (ADA) 86th Scientific Sessions, Diasome reported that HDV-LIS maintained glycemic control with an A1C non-inferiority margin of 30% reductions in both Level 2 hypoglycemic events (glucose 15 consecutive minutes) and extended hypoglycemic events (glucose
“Insulin therapy has always had a narrow therapeutic index: tighter glycemic control directly correlates with increased risk of hypoglycemia. This tradeoff continues to be a major challenge for people living with type 1 diabetes,” said Klara Klein, MD, PhD, Assistant Professor of Medicine, University of North Carolina School of Medicine, and principal investigator in the trial. “In OPTI-2, we see potential to decouple glycemic control from hypoglycemia risk. People randomized to HDV-LIS met similar A1C targets but experienced fewer hypoglycemic events and no severe hypoglycemic events. If confirmed in larger studies, this could allow people living with T1D to achieve glycemic targets with less concern about clinically meaningful hypoglycemia.”
Hypoglycemia Risk in Type 1 Diabetes
Hypoglycemia remains the central dose-limiting barrier in diabetes management. Nearly 2.1 million Americans live with type 1 diabetes.1 Each year, about 20% of adults with type 1 diabetes report at least one severe hypoglycemic event, a rate that persists even among users of the most advanced automated insulin delivery systems.2,3 With standard insulin therapy, tighter glycemic control has been consistently associated with increased hypoglycemia risk—a coupling recognized since the Diabetes Control and Complications Trial (DCCT) in 1993. OPTI-2 may be the first controlled rapid-acting insulin trial to show A1C non-inferiority while simultaneously demonstrating statistically significant reductions in clinically meaningful hypoglycemia.
HDV™-Insulin Lispro
HDV (hepatocyte-directed vesicle) is a phospholipid bilayer bicelle that binds standard insulin lispro and preferentially directs it to hepatocyte receptors, restoring a more physiologic pattern of hepatic insulin exposure. By restoring mealtime liver insulinization, HDV-LIS may improve postprandial glucose disposal and hepatic glycogen storage, potentially reducing the frequency and severity of hypoglycemia.
Study Design
OPTI-2 enrolled 226 adults with type 1 diabetes across 27 U.S. sites and randomized them 1:1 to HDV-LIS or LIS, with unblinded continuous glucose monitoring (Dexcom G7) provided to both groups throughout the study. The trial comprised a 12-week dose optimization period with weekly insulin titration toward intensive glycemic targets, followed by a 13-week maintenance period with stable dosing. The prespecified primary endpoint was a binary composite assessed during dose optimization requiring both A1C non-inferiority and superiority in at least one of three nocturnal CGM-derived hypoglycemia metrics. The design had not been previously used in a blinded insulin trial. Prespecified secondary endpoints assessed the same and additional hypoglycemia metrics during the first and last six weeks of the maintenance period.
Results
A1C non-inferiority was confirmed at Week 12 (HDV-LIS: -0.34% vs. LIS: -0.42%; estimated difference 0.08%; [95% CI: -0.06, 0.21]; p=0.26) and Week 25 (HDV-LIS: -0.31% vs. LIS: -0.38%; estimated difference 0.07%; [95% CI: -0.10, 0.25]; p=0.40), meeting the FDA’s required
At Week 12, 14/15 prespecified CGM hypoglycemia point estimates favored HDV-LIS and met non-inferiority; however, statistically significant superiority was narrowly missed during the 12-week window of active titration. During the maintenance period, the FDA’s preferred time for assessing hypoglycemia data, the HDV-LIS hypoglycemia risk reduction signal strengthened considerably. HDV-LIS produced statistically significant reductions across multiple prespecified secondary endpoints throughout this period:
24-hour Level 2 events: 28% reduction (rate ratio 0.72; p=0.014)Daytime Level 2 hypoglycemic events: 33% reduction (rate ratio 0.67; p=0.009)24-hour percent time below 54 mg/dL: 28% reduction (rate ratio 0.72; p=0.017)Daytime percent time below 54 mg/dL: 32% reduction (rate ratio 0.68; p=0.010)24-hour extended hypoglycemia events: 36% reduction (rate ratio 0.64; p=0.029)
Across the full study, the exposure-adjusted incidence rate of Level 2 hypoglycemia was 25% lower with HDV-LIS than with LIS, and zero HDV-LIS-treated participants experienced a Level 3 severe hypoglycemic event, compared with five in the LIS group (p=0.0598).
Treatment-emergent adverse events were comparable between groups (53.6% HDV-LIS vs. 50.0% LIS). Serious treatment-emergent adverse events occurred in one HDV-LIS participant (0.9%) and eight LIS participants (7.0%). No deaths, diabetic ketoacidosis events, or clinically meaningful hepatic safety signals were observed in either group.
“OPTI-2 demonstrated that HDV-LIS can potentially break the tradeoff between tight glycemic control and hypoglycemia risk, with no severe hypoglycemic events in six months of mealtime dosing and a 25% reduction in Level 2 hypoglycemia across the full study. These results, combined with A1C non-inferiority – the FDA’s preferred endpoint – now demonstrated in two consecutive blinded trials, give us clear support to advance the program into Phase 3,” said Robert Geho, Chief Executive Officer of Diasome. “We also believe the HDV platform has broader potential, with the same liver-targeting approach being explored in metabolic disease and obesity, where targeted hepatic delivery may meaningfully improve clinical outcomes.”
About OPTI-2
OPTI-2 (NCT06238778) was a Phase 2b, double-blind, randomized, parallel-group study conducted at 27 sites in the United States. The trial enrolled 226 adults with type 1 diabetes on multiple daily injection (MDI) therapy and randomized participants 1:1 to bolus insulin with HDV-LIS or standard LIS, both with once-daily insulin degludec as basal insulin and continuous glucose monitoring (Dexcom G7) worn throughout the 25-week treatment period. The study included a 12-week dose optimization period with weekly CGM-guided titration, followed by a 13-week dose maintenance period.
About Diasome Pharmaceuticals
Diasome is a clinical-stage biopharmaceutical company developing therapies to act in the portal-hepatic region, the center of metabolic regulation. The company’s proprietary HDV™ platform delivers therapeutics preferentially to the liver and portal vein. Diasome is applying HDV across insulin, GLP-1, and serotonin programs. Diasome’s lead program, HDV-Insulin, is designed to decouple improved glycemic control from the increased hypoglycemia risk that typically accompanies this essential medicine for millions of patients globally. For more information about Diasome, visit Diasome.com or follow us on LinkedIn or X.
Contacts
Media & Investors:Adam Silversteinadam@scientpr.com
1 Centers for Disease Control and Prevention. National Diabetes Statistics Report website. https://www.cdc.gov/diabetes/php/data-research/index.html.2 Sherr JL, et al. Severe hypoglycemia and impaired awareness of hypoglycemia persist in people with type 1 diabetes despite use of diabetes technology: results from a cross-sectional survey. Diabetes Care. 2024;47(6):941–947. doi:10.2337/dc23-1765.3 Sherr JL, et al. Persistent burden of severe hypoglycemia and impaired awareness of hypoglycemia among people with type 1 diabetes despite technology use: a follow-up survey. Diabetes Care. 2026 Feb 26:dc25-2345. doi:10.2337/dc25-2345.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/4b351397-b1fd-46e2-bed6-a282482409d4
About Web3Wire Web3Wire – Information, news, press releases, events and research articles about Web3, Metaverse, Blockchain, Artificial Intelligence, Cryptocurrencies, Decentralized Finance, NFTs and Gaming. Visit Web3Wire for Web3 News and Events, Block3Wire for the latest Blockchain news and Meta3Wire to stay updated with Metaverse News.
Security researcher Taylor Hornby used Claude Opus 4.8 to discover a four-year-old flaw in Zcash’s Orchard privacy pool that could have enabled unlimited counterfeit ZEC creation.
Cybersecurity researchers say frontier AI models are increasingly capable of finding cryptographic and logic flaws that previously required deep specialist expertise.
Experts warn that capabilities approaching today’s most advanced vulnerability-discovery systems could become widely available within months.
A security researcher using Anthropic’s Claude Opus 4.8 uncovered a critical flaw in Zcash’s Orchard privacy pool in a matter of days, exposing a vulnerability that had survived four years of review by leading zero-knowledge cryptographers.
The disclosure sent ZEC tumbling roughly 38% on Thursday and raised a broader concern for the crypto industry around frontier AI models becoming increasingly proficient in finding vulnerabilities than most humans.
“The significance isn’t really that AI can find bugs,” Ben Goertzel, founder and CEO of SingularityNET, told Decrypt. “It’s that the kind of bug it can now find has changed.”
Rather than simply flagging obvious coding mistakes, frontier models are increasingly capable of reasoning about whether software behaves the way its designers intended, he said.
In May, Taylor Hornby, a security researcher hired by Shielded Labs, discovered a critical flaw in Zcash’s Orchard circuit with assistance from Anthropic’s Claude Opus 4.8. Hidden in two lines of code, the bug stemmed from a check that appeared to validate transaction inputs but wasn’t actually enforcing the intended rules, potentially allowing an attacker to create counterfeit ZEC inside the shielded pool without detection. Hornby built a working exploit to verify the vulnerability before reporting it to developers. An emergency fix was deployed on June 1.
Adding to the panic that hit Zcash and the broader crypto market on Thursday and Friday is the fact that the flaw had been left undiscovered for over four years.
For Goertzel, the discovery is significant not only because AI found a vulnerability, but also because it points to a new model for security research.
“I think it’s an early marker of a shift that’s going to be hard to overstate,” he said. “The model of security research as a handful of revered human specialists doing slow, artisanal, deeply-expert audits doesn’t go away, but it stops being the whole game.”
Goertzel said the Orchard flaw belongs to a class of subtle logic bugs that frontier AI models are increasingly capable of finding, including smart-contract errors, access-control failures, and situations where software behaves differently than its designers intended. As those capabilities improve, he added that security research is shifting toward a model in which human specialists oversee continuous AI-driven review that can analyze codebases far more extensively than traditional audits.
The Zcash response itself may offer a preview of that future, Goertzel said.
“Shielded Labs bringing on a researcher specifically to hunt protocol-level flaws with a frontier model before a malicious actor could is, I suspect, the template, not the exception,” Goertzel said. “Proactive, AI-augmented, adversarial-by-design review becomes table stakes, and the protocols that don’t adopt it will increasingly be the ones learning about their vulnerabilities from the attacker rather than from a friendly.”
According to Sean Ren, CEO of Sahara AI and a computer science professor at the University of Southern California, advances in AI are also reshaping the balance between attackers and defenders as frontier models can rapidly test attack strategies, learn from the results, and uncover weaknesses.
“In order to build up better defense, we have to use these frontier AI models as the potential attackers to stress test these systems,” Ren told Decrypt.
Ren said blockchain networks are especially exposed because their open-source code can be analyzed directly by frontier AI models, which can rapidly test attack strategies and identify vulnerabilities faster than traditional security reviews.
“If you think about frontier model labs like OpenAI, Anthropic, and Google DeepMind, they have earlier access to the strongest unpublished models and can conduct a lot of experiments on public network systems like blockchains, so they do have the power at hand,” he said. “If someone with malicious intent had access to those capabilities, they could conduct attacks and create vulnerabilities.”
That window may close faster than many expect, and according to Danny Jenkins, CEO and co-founder of cybersecurity firm ThreatLocker, AI-assisted vulnerability discovery is improving faster than many organizations can secure the software they already rely on.
“We have this huge gap that’s going to take years and years to get through,” Jenkins told Decrypt. “All of this software is going to have all of these vulnerabilities, we’re not going to have fixes or updates for it for a long time, and people are going to be able to find those vulnerabilities very quickly.”
Jenkins said AI is not fundamentally changing vulnerability research so much as dramatically accelerating it. Tasks that once required security researchers to review code and reverse engineer software manually can now be performed in seconds by modern models.
“Pre-AI, cybersecurity threats and exploits were increasing every year,” he said. “Post-AI, it’s become even faster, and I think it’s become faster for two reasons. One is that you can now use AI to help find vulnerabilities and exploits, and the number of people who have the ability to do this has massively grown. You don’t have to be a script kiddie now.”
Despite those risks, Goertzel argued that crypto may also be better positioned than other industries to adapt because its code is open, and its communities are highly security-focused.
“Crypto is standing closest to the door, but it’s also the part of the room that can see the door coming,” he said.
Daily Debrief Newsletter
Start every day with the top news stories right now, plus original features, a podcast, videos and more.
Arthur Hayes warned that Hyperliquid’s use of trading fees to burn tokens exposes the protocol to market share losses.
Less than two months after predicting HYPE would hit $150, BitMEX co-founder Arthur Hayes liquidated his entire position.
Despite Hyperliquid securing $3 billion in real-world asset open interest, Hayes anticipates fierce competition from Wall Street.
Hyperliquid has surfaced as crypto’s derivatives darling since it debuted in 2023, but the honeymoon may not last forever, according to BitMEX co-founder Arthur Hayes.
Although the decentralized upstart’s surging popularity has helped spur its native token to recent all-time highs, the outspoken Hayes told Decrypt in an interview that looming competition from Wall Street and established crypto players threatens to erode one of the digital asset’s core drivers.
Hyperliquid relies on a steady stream of trading fees to buy its token off the open market and permanently remove it from circulation—a mechanism designed to bolster scarcity, that Hayes warned, leaves the protocol uniquely exposed to any sudden loss in market share.
“At the end of the day, this is a cash story,” he said. “There will be more competition in real-world asset perps, whether that’s from centralized exchanges like Binance [or] TradFi exchanges.”
Arthur Hayes (@CryptoHayes) emerged as one of Hyperliquid’s biggest cheerleaders as its token rallied to all-time highs.
On Thursday, he said he “dumped” his holdings. These are potential risks he thinks the decentralized upstart could face: pic.twitter.com/ZS5SYl2CIJ
— Decrypt (@DecryptMedia) June 4, 2026
A day after his interview, Hayes informed followers on X that he had “just dumped” his entire stash of HYPE tokens, alongside another digital asset. He cited an expected uptick in energy prices, a string of oxygen-sucking IPOs, and an about-face by President Trump on AI.
“Time to take profit,” he added, less than two months after penning and sharing an essay on why Hyperliquid’s native token “is going to $150 by August 2026.”
HYPE changed hands around $59 on Sunday, a 14% decrease over the past seven days, according to CoinGecko. The asset notched a fresh all-time high above $75 last week. Hayes’ sudden shift rubbed some onlookers the wrong way, but during the interview, he lauded Hyperliquid’s ascent as a venue for trading otherwise illiquid markets on the weekend—especially for oil.
“Perennial crypto haters had to acknowledge that price action and price discovery for these key variables happen over the weekend on a crypto trading platform,” he said. “I think this is a watershed moment, and what caused people to wake up.”
Hyperliquid began supporting derivatives for real-world assets, including gold and silver, via an October upgrade. On Tuesday, the platform’s official X account said that the total value of outstanding positions tied to such markets had reached $3 billion.
So far, the platform has bought back 26.6 million HYPE, while permanently removing 579,603 HYPE from circulation, according to a Dune dashboard. The larger sum represents around $1.56 billion worth of Hyperliquid’s native token at current prices.
Hayes noted that U.S. giants are aggressively pushing into the perpetual futures space. Unlike traditional futures, the derivatives—also known as perps—don’t expire, allowing traders to speculate indefinitely amid periodic payments that keep prices anchored.
Under Hayes, BitMEX debuted the world’s first perpetual futures contract in 2016, a concept established long ago in the early ’90s by Nobel Prize-winning economist Robert Shiller. These days, Hayes predicts that Wall Street incumbents will eventually adopt the products to survive.
“All these traditional exchanges are going to be forced to launch a competing product,” he said. “By next year, we’re going to see some decently liquid products in TradFi that use this perpetual swap architecture.”
Daily Debrief Newsletter
Start every day with the top news stories right now, plus original features, a podcast, videos and more.
HANOVER, Germany, June 07, 2026 (GLOBE NEWSWIRE) — Astrall Dynamics unveiled the Hypertron-T01 firefighting robot at INTERSCHUTZ 2026. The heavy-duty quadruped robot features an 80kg dynamic payload capacity paired with a fully integrated high-pressure water cannon, effectively resolving the industry’s long-standing trade-off between robotic mobility and active fire suppression capabilities.
The system carries a high-pressure water cannon while simultaneously dragging heavy supply hoses through complex debris. The integrated water cannon delivers a 20L/s flow rate with a 60-meter range and a 120-degree projection angle. An advanced body stabilization system for effective fire suppression while the robot climbs 45-degree slopes or navigates narrow chemical pipelines, all controlled via secure remote methods. IP67 protection supports operation in rain, dust, mud, and wet environments. The platform is also designed for a wide operating temperature range from -20°C to 55°C. Furthermore, an 8-hour runtime prevents the unit from losing power mid-operation, while integrated thermal imaging, gas detection, and 3D LiDAR provide continuous situational awareness.
The Hypertron-T01 is designed to enter environments with high temperatures, toxic gases, or structural collapse risks for active suppression and reconnaissance. By deploying the robot into the hazard zone, human operators can remain in a safe area to make strategic, data-driven decisions.
The system’s design is driven by real-world rescue pain points. This field validation is backed by the system’s completed bulk delivery to China Southern Power Grid, with global orders now being accepted.
“Traditional quadruped robots typically have a low payload and lack all-terrain mobility,” said Xinqi, head of international business at Astrall Dynamics. “Our quadruped robot Hypertron-T01 can carry a full set of firefighting equipment into burning stairwells and collapsed buildings, helping reduce firefighters’ exposure to the most dangerous front-line environments.”
As the global rescue robotics market grows and fire departments integrate firefighting robots into standard equipment frameworks, Astrall Dynamics continues to expand its international footprint.
About Astrall Dynamics
Astrall Dynamics is a Shenzhen-based robotics company specializing in embodied intelligence. With a core team originating from a leading Chinese drone manufacturer, the company is backed by Pre-A round industrial venture capital.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/83f00aee-0e86-433a-bc65-cf789b0eba2a
About Web3Wire Web3Wire – Information, news, press releases, events and research articles about Web3, Metaverse, Blockchain, Artificial Intelligence, Cryptocurrencies, Decentralized Finance, NFTs and Gaming. Visit Web3Wire for Web3 News and Events, Block3Wire for the latest Blockchain news and Meta3Wire to stay updated with Metaverse News.
Largo, FL, June 06, 2026 (GLOBE NEWSWIRE) — SlimTide is a ketogenic support supplement created to help individuals pursuing weight-management goals through nutritional ketosis. The formula features a specialized blend of exogenous ketones designed to complement a low-carbohydrate lifestyle and support metabolic efficiency.
SlimTide: A Complete Consumer Guide
As obesity rates and lifestyle-related health concerns continue to rise worldwide, consumers are increasingly exploring wellness products designed to support healthy weight management. Among the supplements attracting attention in the nutrition and wellness sector is SlimTide Capsules, a metabolism-support formula marketed as a natural aid for individuals seeking long-term weight management support.
Explore Official Know More SlimTide
Health experts note that maintaining a healthy body weight has become increasingly difficult for many adults due to sedentary lifestyles, processed food consumption, chronic stress, inadequate sleep, and demanding work schedules. These factors can contribute to weight gain, reduced energy levels, and challenges in maintaining consistent healthy habits.
Rather than promoting rapid or extreme weight-loss results, SlimTide is positioned as a supplement intended to complement healthy lifestyle practices, including balanced nutrition, regular exercise, hydration, and adequate rest.
Understanding the Role of Metabolism
Metabolism refers to the body’s complex process of converting food into energy required for essential functions such as breathing, circulation, digestion, cellular repair, and physical activity. The efficiency of these metabolic processes can influence how the body utilizes calories and manages energy throughout the day.
According to health professionals, several factors can affect metabolic performance, including age, genetics, muscle mass, hormone levels, sleep quality, stress, and overall physical activity.
A slowdown in metabolic activity may contribute to reduced calorie expenditure, making weight management more challenging for some individuals.
Why Weight Management Remains a Challenge
Experts point to several modern lifestyle factors that may interfere with maintaining a healthy body weight:
Sedentary Habits
Many adults spend significant portions of their day sitting at desks, commuting, or using digital devices. Reduced movement can lower daily calorie expenditure and contribute to gradual weight gain.
Increased Consumption of Processed Foods
Convenient packaged meals, sugary beverages, and highly processed snacks often contain excessive calories while offering limited nutritional value.
Chronic Stress
Research suggests that prolonged stress may influence eating behaviors and contribute to cravings for high-calorie comfort foods. Stress-related hormonal changes may also affect fat storage patterns.
Sleep Deficiency
Insufficient sleep has been linked to appetite regulation challenges, reduced energy levels, and metabolic disruptions that may complicate weight management efforts.
Aging and Muscle Loss
As individuals age, natural declines in muscle mass and metabolic activity can make maintaining a healthy weight increasingly difficult without lifestyle adjustments.
What Is SlimTide?
SlimTide Capsules are marketed as a dietary supplement formulated to support metabolism, energy balance, appetite management, and overall wellness.
The supplement is designed for individuals looking to incorporate additional nutritional support into an existing health-focused routine rather than relying solely on restrictive dieting methods.
Industry analysts note that consumer interest in supplements addressing multiple wellness concerns simultaneously has grown significantly in recent years.
Ingredients Commonly Associated with Metabolic Support
While ingredient formulations may vary, many metabolism-support supplements include compounds that have been studied for their potential role in weight management and energy production.
Green Tea Extract
Green tea extract is frequently included in wellness supplements due to its antioxidant content and naturally occurring caffeine.
Researchers have investigated green tea compounds for their potential role in supporting metabolism, energy levels, and fat oxidation.
Garcinia Cambogia
Derived from a tropical fruit, Garcinia Cambogia has been widely used in weight-management products. It contains hydroxycitric acid (HCA), a compound often associated with appetite-support research.
Apple Cider Vinegar
Apple cider vinegar remains a popular ingredient in health and wellness products due to its potential role in digestive support and appetite awareness.
Chromium
Chromium is a trace mineral involved in nutrient metabolism and blood sugar regulation. Some studies suggest it may assist with maintaining healthy carbohydrate metabolism.
L-Carnitine
L-Carnitine plays a role in transporting fatty acids into cells where they can be used for energy production. It is commonly included in sports nutrition and weight-management supplements.
Dietary Fiber
Fiber is recognized for its importance in digestive health and satiety, helping individuals feel fuller for longer periods.
Lifestyle Factors Remain Essential
Nutrition professionals emphasize that supplements alone are unlikely to produce meaningful or lasting weight-management results without healthy lifestyle habits.
Experts recommend focusing on:
Balanced Nutrition
A diet rich in fruits, vegetables, lean proteins, whole grains, and healthy fats can support metabolic health and overall wellness.
Regular Physical Activity
Activities such as walking, strength training, cycling, swimming, and yoga can help increase calorie expenditure and preserve muscle mass.
Hydration
Proper water intake supports digestion, nutrient transport, and energy production while potentially reducing unnecessary snacking linked to thirst.
Sleep Optimization
Quality sleep remains one of the most important factors in maintaining energy balance and supporting healthy metabolism.
Stress Management
Mindfulness practices, exercise, relaxation techniques, and structured routines may help individuals maintain healthier eating and lifestyle habits.
Potential Benefits Reported by Users
Consumers interested in SlimTide often seek support in several wellness areas, including:
Improved energy levelsBetter adherence to healthy routinesAppetite managementDigestive comfortMetabolic supportLong-term weight management assistance
Health professionals caution that individual results may vary significantly depending on diet, exercise habits, age, genetics, and overall health status.
The Importance of Realistic Expectations
Nutrition experts continue to stress that sustainable weight management typically occurs gradually rather than through rapid transformations.
Long-term success is often associated with consistent lifestyle habits, realistic goal setting, and ongoing behavioral changes rather than short-term restrictive approaches.
Supplements such as SlimTide are generally intended to support broader wellness efforts rather than replace healthy eating patterns and physical activity.
Consumer Interest in Natural Wellness Solutions Continues to Grow
The popularity of metabolism-support supplements reflects a broader trend toward holistic wellness strategies. Consumers increasingly seek products that align with sustainable health practices and support overall well-being rather than focusing exclusively on weight loss.
Industry observers suggest that products emphasizing balanced energy, metabolism support, appetite awareness, and healthy lifestyle integration may continue gaining traction as consumers prioritize long-term health outcomes.
Final Outlook
As interest in natural wellness and weight-management solutions grows, supplements such as SlimTide are becoming part of a broader conversation about sustainable health habits and metabolic support.
While supplements may offer additional support for some individuals, healthcare professionals continue to emphasize that balanced nutrition, regular exercise, quality sleep, stress management, and consistency remain the foundation of successful long-term wellness and healthy weight management.
Consumers considering any dietary supplement are encouraged to review product information carefully and consult qualified healthcare professionals before beginning a new wellness regimen, particularly if they have existing medical conditions or take prescription medications.
Core Mechanism
At the center of SlimTide’s formula is an 800 mg ketone complex containing Beta-Hydroxybutyrate (BHB) salts. These compounds are intended to increase ketone availability in the body, providing an alternative fuel source when carbohydrate intake is reduced.
Manufacturing Standards
SlimTide is manufactured in the United States in an FDA-registered facility that follows established quality-control procedures. The product is promoted as GMO-free and produced using carefully selected ingredients.
Explore Official Know More SlimTide
Usage Instructions
The suggested serving size is two capsules per day taken with a full glass of water. For best results, users are encouraged to combine SlimTide with a ketogenic nutrition plan emphasizing healthy fats, moderate protein intake, and minimal carbohydrates.
Official Access
To ensure authenticity, quality assurance, and access to customer support, consumers should obtain SlimTide only from authorized purchasing channels.
Is SlimTide a Scam or Legit?
One of the most frequently searched questions about SlimTide is whether the supplement is a scam or a legitimate weight-management product. The answer requires a careful evaluation of the product’s ingredients, claims, transparency, and intended purpose.
Based on the available information, SlimTide appears to be a legitimate dietary supplement that utilizes Beta-Hydroxybutyrate (BHB) ketone salts, ingredients commonly found in ketogenic support products. BHB is a well-known exogenous ketone that has been studied for its ability to increase blood ketone levels and provide an alternative source of energy during carbohydrate restriction.
However, legitimacy does not automatically guarantee effectiveness for every user. Consumers should understand the difference between a legitimate supplement and exaggerated marketing claims. While BHB supplements have scientific support for increasing ketone availability, there is limited evidence suggesting that ketone supplements alone produce dramatic or effortless weight loss without dietary and lifestyle changes.
A key factor in evaluating SlimTide is transparency. Legitimate supplement companies typically provide ingredient information, dosage guidelines, safety recommendations, and customer support resources. Consumers should carefully review the product label, usage instructions, and company policies before making a purchase.
Another important consideration is marketing language. If advertisements promise rapid fat loss, overnight transformations, or guaranteed results, those claims should be approached with caution. Sustainable weight management generally requires a combination of balanced nutrition, physical activity, consistency, and healthy lifestyle habits.
Consumers should also be aware of counterfeit products and unauthorized sellers. Purchasing supplements from unofficial sources may increase the risk of receiving altered, expired, or counterfeit products. Verifying the authenticity of the seller and reviewing return policies can help reduce these risks.
When evaluating customer reviews, it is helpful to look for feedback across multiple independent platforms rather than relying solely on testimonials featured in promotional materials. Individual experiences can vary significantly based on factors such as metabolism, diet, activity level, and overall health status.
Red Flags to Watch For
Before purchasing SlimTide or any dietary supplement, consider the following warning signs:
Claims of effortless or guaranteed weight lossUnrealistic before-and-after photosFake celebrity endorsementsHidden subscription or auto-renewal programsMissing ingredient informationLack of customer service contact detailsNo clear refund or return policy
Signs of a Legitimate Supplement
Features commonly associated with reputable dietary supplements include:
Based on the available ingredient information and intended use, SlimTide does not appear to be an obvious scam. It contains commonly used ketogenic support ingredients and follows the general structure of many exogenous ketone supplements currently available in the marketplace.
That said, consumers should maintain realistic expectations. SlimTide is not a miracle weight-loss solution, and no supplement can replace the benefits of healthy eating, regular exercise, adequate sleep, and long-term lifestyle improvements.
The most balanced conclusion is that SlimTide appears to be a legitimate dietary supplement designed to support ketogenic lifestyles, but its effectiveness will vary among individuals and should be viewed as one component of a broader health and wellness strategy.
Scientific Evidence and Ingredient Efficacy
Ketone Foundation
SlimTide contains three forms of Beta-Hydroxybutyrate salts: Magnesium BHB, Calcium BHB, and Sodium BHB. These ketone compounds are commonly used in ketogenic supplements because they can help elevate circulating ketone levels.
Metabolic Support
By supplying exogenous ketones, SlimTide may assist the body in adapting to carbohydrate restriction. These ketones can serve as a supplemental energy source for both physical and cognitive activities.
Electrolyte Balance
Ketogenic diets can affect electrolyte status due to changes in fluid balance. The mineral-bound ketones found in SlimTide provide sodium, calcium, and magnesium alongside BHB, potentially supporting electrolyte maintenance.
SlimTide Transparency and Consumer Safety
Label Transparency
SlimTide provides ingredient information directly on its product label, allowing consumers to understand the contents of the formula before use.
No Artificial Additives
The formula is marketed as free from artificial stimulants and focuses on ketone-based nutritional support rather than stimulant-driven energy enhancement.
Allergen Information
Consumers should carefully review the complete ingredient list, especially if they have known sensitivities to capsule materials or manufacturing additives.
Medical Disclaimer
SlimTide is intended as a dietary supplement and should not be considered a treatment, cure, or preventive measure for any medical condition. Professional medical advice is recommended before beginning any supplement regimen.
Safety Seal
Always inspect product packaging before use. Any package showing signs of tampering or a broken safety seal should not be consumed.
Storage Requirements
Store SlimTide in a cool, dry location away from direct sunlight, humidity, and excessive temperatures to help maintain product quality.
SlimTide Marketplace Risks and Consumer Guidance
Unauthorized Sellers
The popularity of ketogenic supplements has led to an increase in unauthorized online listings. Consumers should exercise caution when purchasing products from unverified third-party sellers.
Fake Endorsements
Be cautious of marketing campaigns that use unrealistic testimonials, fabricated celebrity endorsements, or heavily edited transformation photos. Reliable information should come from transparent product disclosures and credible research.
Verification
Purchasing from verified sources can help ensure product authenticity and reduce the risk of receiving counterfeit or altered supplements.
SlimTide Usage Timeline and Expectations
Initial Phase (Weeks 1-4)
During the first month, some users may notice changes in energy levels, appetite control, or adaptation to a ketogenic eating pattern as the body becomes more accustomed to utilizing ketones.
Long-Term Phase (Weeks 4-12+)
Longer-term outcomes depend on consistency, dietary adherence, physical activity, and individual metabolic factors. Sustainable results generally require ongoing commitment to healthy lifestyle habits.
Final Recommendations
Consultation
Before incorporating SlimTide into your wellness routine, consult a qualified healthcare professional, especially if you have existing health conditions or use prescription medications.
Consistency
Following the recommended serving guidelines consistently may help users experience the intended benefits of the formula.
Vigilance
Remain cautious when purchasing dietary supplements online and verify product authenticity before completing any transaction.
The Rise of SlimTide and Why Consumers Need This Warning
Interest in ketogenic supplements continues to grow as more individuals seek alternatives to traditional weight-management strategies. SlimTide has emerged as a product designed to support ketosis and metabolic wellness. However, growing demand often attracts counterfeit sellers and misleading marketing practices, making consumer awareness more important than ever.
Understanding SlimTide: Formula, Ingredients, and Intended Purpose
SlimTide is formulated around an advanced BHB ketone complex intended to support ketosis, energy production, and metabolic adaptation. Rather than functioning as a standalone solution, the supplement is designed to complement a comprehensive health and nutrition strategy.
The SlimTide Ingredient Profile
Magnesium Beta Hydroxybutyrate
What it is: A combination of Beta-Hydroxybutyrate and magnesium.
The Science: This ingredient provides exogenous ketones while supplying magnesium, an essential mineral involved in muscle function, energy production, and nervous system support.
Evidence Quality: Strong. Research consistently demonstrates that exogenous ketones can temporarily increase ketone concentrations in the bloodstream.
Calcium Beta Hydroxybutyrate
What it is: A BHB compound bound to calcium.
The Science: Calcium BHB contributes to ketone availability while also supplying calcium, a mineral important for bone strength and muscle contraction.
Evidence Quality: Moderate to Strong. Scientific literature supports the role of BHB salts in ketogenic supplementation.
Sodium Beta Hydroxybutyrate
What it is: A sodium-bound form of Beta-Hydroxybutyrate.
The Science: Sodium BHB delivers ketones while supporting electrolyte balance, an important consideration for individuals following carbohydrate-restricted diets.
Evidence Quality: Moderate to Strong. Widely utilized in exogenous ketone formulations to support ketosis and hydration balance.
The Science of Exogenous Ketones and SlimTide
The foundation of SlimTide is built around exogenous ketones, specifically Beta-Hydroxybutyrate (BHB) salts. To understand how the supplement is intended to function, it is helpful to first understand the role ketones play in human metabolism.
Under normal dietary conditions, carbohydrates serve as the body’s primary energy source. When carbohydrate intake is significantly reduced, the body begins converting stored fat into molecules known as ketone bodies. This metabolic state is called ketosis. During ketosis, ketones can be used as an alternative fuel source by the brain, muscles, and other tissues.
SlimTide contains exogenous ketones, which are supplemental ketones consumed from an external source rather than produced naturally by the body. These ketones are designed to temporarily increase circulating ketone levels and provide additional fuel during periods of carbohydrate restriction.
The formula utilizes a combination of Magnesium Beta-Hydroxybutyrate, Calcium Beta-Hydroxybutyrate, and Sodium Beta-Hydroxybutyrate. These mineral-bound ketones are commonly used in ketogenic supplements because they offer stability, absorption support, and additional electrolyte benefits.
One challenge often experienced during ketogenic dieting is the loss of key electrolytes through increased fluid excretion. Sodium, calcium, and magnesium levels may fluctuate as the body adapts to carbohydrate restriction. By combining BHB with these essential minerals, SlimTide aims to provide both ketone support and electrolyte replenishment.
Scientific research has shown that exogenous ketones can elevate blood ketone concentrations relatively quickly after consumption. Some studies suggest that ketone supplementation may help support cognitive performance, exercise endurance, and energy availability under certain conditions. However, research regarding long-term weight loss outcomes remains ongoing.
It is important to recognize that exogenous ketones do not replace healthy nutrition. While supplements such as SlimTide may complement a ketogenic lifestyle, sustained weight management typically depends on overall dietary habits, physical activity levels, sleep quality, and calorie balance.
For individuals following a low-carbohydrate or ketogenic eating plan, SlimTide is designed to function as a supportive nutritional tool rather than a standalone solution.
Evaluating the Claims: Does SlimTide Work?
One of the most common questions consumers ask is whether Slim Tide actually delivers meaningful results. The answer depends on understanding what the supplement is designed to do and what it is not intended to accomplish.
The primary mechanism behind Slim Tide involves supplying exogenous ketones to the body. Research supports the ability of BHB salts to increase blood ketone levels temporarily. This may help provide an alternative source of energy, particularly during periods of reduced carbohydrate intake.
Some users report experiencing benefits such as:
Increased daily energy levelsImproved adherence to ketogenic dietsReduced cravings for carbohydratesEnhanced focus and mental clarityBetter support during ketogenic adaptation
These reported effects are generally consistent with the known physiological role of ketones as an alternative energy source.
However, it is important to separate ketone supplementation from direct fat loss. Simply consuming ketones does not automatically cause the body to burn stored body fat. Sustainable weight reduction typically requires a combination of healthy eating habits, physical activity, and long-term consistency.
SlimTide may support individuals who are already committed to a ketogenic lifestyle by helping them maintain ketone availability and potentially easing the transition into ketosis. However, consumers should be cautious of unrealistic marketing claims that promise dramatic or effortless weight loss.
Like all dietary supplements, individual results may vary based on factors including:
Current body compositionMetabolic healthDietary adherenceExercise habitsAge and lifestyle factorsConsistency of use
When viewed realistically, SlimTide may serve as a supportive component within a comprehensive health and wellness plan rather than a miracle solution.
Frequently Asked Questions About SlimTide
1. What is Slim Tide?
Slim Tide is a dietary supplement formulated with exogenous ketone salts designed to support ketosis, energy production, and metabolic adaptation during low-carbohydrate or ketogenic dieting.
2. What ingredients are found in SlimTide?
The formula contains an 800 mg ketone blend featuring Magnesium Beta-Hydroxybutyrate, Calcium Beta-Hydroxybutyrate, and Sodium Beta-Hydroxybutyrate, along with standard capsule ingredients.
3. How does SlimTide work?
Slim Tide provides exogenous ketones that may increase blood ketone levels and offer an alternative source of energy when carbohydrate intake is reduced.
4. Can SlimTide help with weight management?
Slim Tide is intended to support a ketogenic lifestyle and may assist individuals pursuing weight-management goals. However, long-term results depend on nutrition, exercise, consistency, and overall lifestyle habits.
5. Does SlimTide contain stimulants?
According to product information, Slim Tide does not rely on caffeine or other stimulant-based ingredients for its intended effects.
6. How should SlimTide be taken?
The suggested serving is two capsules daily with water. Users should follow all label directions and recommendations.
7. How long does it take to notice results?
Experiences vary among individuals. Some users report noticing changes in energy and appetite management within the first few weeks, while broader wellness goals generally require longer-term consistency.
8. Are there any side effects?
Some individuals may experience mild digestive discomfort when first introducing ketone supplements. Any concerns should be discussed with a healthcare professional.
9. Is Slim Tide suitable for everyone?
Slim Tide may not be appropriate for pregnant women, nursing mothers, individuals under 18 years of age, or those with medical conditions unless approved by a healthcare provider.
10. Can I take SlimTide with medications?
Anyone taking prescription medications should consult a qualified healthcare professional before starting any new supplement.
11. Does SlimTide require a ketogenic diet?
While the supplement is designed to complement ketogenic lifestyles, individual dietary preferences vary. Results may differ depending on nutritional habits and metabolic goals.
12. Is SlimTide a replacement for healthy eating?
No. Slim Tide is intended to supplement a healthy lifestyle and should not be viewed as a substitute for balanced nutrition or regular physical activity.
13. What should I do if I suspect a counterfeit product?
Discontinue use immediately and contact the appropriate customer support channel for verification and guidance.
Important Disclaimers
Medical Disclaimer
The information presented in this article is provided for educational and informational purposes only. It should not be interpreted as medical advice, diagnosis, or treatment. Always seek guidance from a qualified healthcare professional before beginning any dietary supplement program.
Accuracy Notice
Product formulations, ingredient lists, and company policies may change over time. Consumers should verify current information directly from official product documentation before making purchasing decisions.
Endorsement Disclaimer
This article is intended to provide general educational information regarding SlimTide and exogenous ketones. It does not constitute an endorsement, guarantee, or promise of specific results.
Affiliate Disclosure
Some publishers may receive compensation from qualifying purchases made through affiliate partnerships. Such arrangements do not influence editorial integrity or consumer pricing.
Conclusion: A Balanced Perspective on SlimTide
SlimTide is a ketone-based dietary supplement formulated with Magnesium Beta-Hydroxybutyrate, Calcium Beta-Hydroxybutyrate, and Sodium Beta-Hydroxybutyrate. Its primary goal is to support ketosis, provide alternative energy, and complement individuals pursuing ketogenic or low-carbohydrate lifestyles.
The scientific foundation behind exogenous ketones is well established. Research demonstrates that BHB supplementation can increase circulating ketone levels and provide an alternative energy source during carbohydrate restriction. Additionally, the inclusion of essential mineral salts may help support electrolyte balance during ketogenic dieting.
However, consumers should maintain realistic expectations. No supplement can replace the importance of proper nutrition, regular exercise, adequate sleep, and long-term healthy habits. Weight management remains a multifaceted process influenced by numerous biological and lifestyle factors.
For individuals seeking ketogenic support, SlimTide may offer benefits when used consistently alongside an appropriate nutrition and fitness plan. As with any dietary supplement, consulting a healthcare professional before use is strongly recommended.
Ultimately, informed decision-making, realistic goals, and a commitment to overall wellness are the keys to achieving sustainable results.
About Web3Wire Web3Wire – Information, news, press releases, events and research articles about Web3, Metaverse, Blockchain, Artificial Intelligence, Cryptocurrencies, Decentralized Finance, NFTs and Gaming. Visit Web3Wire for Web3 News and Events, Block3Wire for the latest Blockchain news and Meta3Wire to stay updated with Metaverse News.
Frontier AI models are increasingly being used to identify software vulnerabilities.
Claude Mythos, Claude Opus, GPT-5.5, and other systems have been deployed in vulnerability research across browsers, operating systems, and open-source software.
The technology is beginning to influence crypto and DeFi security, where Claude Opus 4.8 was cited in research that uncovered a critical Zcash vulnerability.
The latest generation of frontier AI models are no longer just chatting with users, generating images, or writing code. Researchers are increasingly using systems such as Anthropic’s Claude Mythos and Claude Opus 4.8 and OpenAI’s GPT-5.5 to identify software vulnerabilities, raising concerns about what happens when those capabilities become widely available.
Crypto investors got a wake-up call about the rising threat from powerful AI this week when Zcash developers disclosed that Claude Opus 4.8 helped discover a critical vulnerability that could’ve enabled an attacker to mint unlimited ZEC. Due to the network’s design, there’s no current way to know for sure whether counterfeit ZEC was, in fact, minted—and that uncertainty led to the price of ZEC crashing late this week.
Experts warn that many more vulnerabilities could be found in the coming weeks and months as AI software gets more capable—and those tools become more accessible. Here’s a look at the growing threat, and how it’s already impacted the crypto world.
Early AI models were professionally used as coding assistants, helping developers write, explain, and debug software. As the technology improved, researchers began using the same systems for code review, software auditing, and vulnerability research.
The transition from coding assistant to security tool coincided with a broader shift in how AI was being used inside software development. After the launch of Claude Code in 2025, Anthropic reported a sharp increase in AI-generated code across its engineering teams, reflecting a move from models that suggested code to systems capable of writing and running it.
Security professionals say the implications extend beyond helping developers write code.
“AI is far better at reviewing code than most people and finding potential vulnerabilities in it,” Danny Jenkins, CEO and co-founder of ThreatLocker, told Decrypt. Jenkins said current AI systems are already accelerating vulnerability discovery, while newer models such as Mythos could significantly expand those capabilities, calling it an imminent “big problem.”
“It will be only a matter of time until someone bad gets access to it,” he said.
According to Jenkins, AI is also lowering the barriers to entry for vulnerability research, allowing more people to analyze code, identify weaknesses, and develop exploits. As access to increasingly capable systems expands, he expects the pace of vulnerability discovery to increase.
“Pre-AI, cybersecurity threats and exploits were increasing every year,” he said. “Post-AI, it’s become even faster, and I think it’s become faster for two reasons. One is that you can now use AI to help find vulnerabilities and exploits, and the number of people who have the ability to do this has massively grown. You don’t have to be a script kiddie now.”
As AI systems became more capable, companies began applying them to cybersecurity. On Tuesday, Anthropic expanded access to Project Glasswing, giving 150 companies and institutions access to Claude Mythos to help identify and remediate software vulnerabilities before the model is released more broadly.
In April, Mozilla later disclosed that Anthropic’s models helped identify hundreds of vulnerabilities that it fixed in the Firefox web browser, while researchers at Calif used Mythos Preview during work that produced one of the first public exploits targeting Apple’s M5 chips.
Stanislav Fort, a former researcher at Google DeepMind and Anthropic and now founder and chief scientist of security firm Aisle, said concerns about AI-powered vulnerability discovery are valid, but often misunderstood.
“The naive response is to try to gatekeep access to powerful models. I think this is essentially security by obscurity, and security by obscurity is one of the worst ideas in the field,” Fort told Decrypt. “The capability for zero-day discovery is already widely distributed across models that no one can restrict. Trying to bottle it up at the frontier doesn’t eliminate the risk; it just delays it while also slowing down the defenders who need these tools most.”
Fort said the greater risk is that defenders, particularly open-source maintainers, may lack access to the same advanced AI tools available to attackers.
“That imbalance is the real danger,” he said. “The answer isn’t restriction; it’s democratization of the defensive stack.”
Anthropic is not alone in pushing AI models aimed at cybersecurity. In May, Microsoft introduced MDASH, an agentic vulnerability discovery system that the company said helped identify previously unknown Windows vulnerabilities.
The risk to crypto
Crypto and DeFi are starting to feel the impact of AI-powered bug hunting. Blockchain projects have always been attractive targets because there is a lot of money at stake and much of the code is publicly available. Jenkins said as AI gets better at finding software flaws, open-source crypto projects could become easier targets for both security researchers looking for bugs and attackers looking to exploit them.
In one of the clearest examples of how advanced AI models can help researchers uncover vulnerabilities that had survived years of human review, independent security researcher Taylor Hornby disclosed the critical vulnerability in Zcash’s Orchard privacy pool that he discovered with the assistance of Claude Opus 4.8.
The flaw could have allowed an attacker to create unlimited counterfeit ZEC, and had gone undetected for years before being patched. Whether the exploit was actually used currently remains unknown.
“The vulnerability was present from Orchard’s activation in May 2022 until the emergency fix was deployed on June 1, 2026,” Shielded Labs, the organization behind Zcash development, wrote in a disclosure post. “Due to the privacy properties of Orchard and the nature of the bug, there is no definitive way to determine, using only cryptography, whether such exploitation occurred.”
The attack comes as DeFi protocols are already facing one of their worst years for exploits. More than $840 million was stolen from DeFi projects in the first five months of 2026, including more than $600 million in April alone across attacks on projects including KelpDAO, and Drift Protocol.
The rise of so-called ‘vibe hacking,’ where attackers use AI coding agents to automate reconnaissance, credential theft, malware development, and other tasks, has raised concerns that AI is lowering the barriers to carrying out sophisticated cyberattacks
According to Natalie Newson, senior blockchain investigator at Web3 security platform CertiK, while April was unusually severe for crypto exploits, the broader trend remains more stable and below the peak number of incidents seen in past years.
“April 2026 was a bad month for crypto exploits; there were only three days without an exploit in which at least $10,000 was taken,” she said. “However, when we take a look at the wider picture, the number of incidents (excluding phishing) has arguably been fairly consistent and still lower than a peak in 2023.”
While AI is making DeFi exploits easier to carry out, according to Blockaid CTO Raz Niv, the bigger risk is not AI replacing hackers but amplifying them, allowing attackers to focus on more sophisticated techniques while AI handles routine tasks.
“The good news is defenders can use the same tools,” he said. “AI-assisted monitoring and simulation is becoming essential for security teams trying to keep pace.”
Daily Debrief Newsletter
Start every day with the top news stories right now, plus original features, a podcast, videos and more.
![SlimTide Capsules [UPDATED WARNING 2026] Slim Tide Uncovering the Real Truth Behind the Trending Weight Loss Supplement | Web3Wire](https://i2.wp.com/web3wire.org/wp-content/uploads/2026/06/slimtide-guide.png?w=640&resize=640,0&ssl=1 "SlimTide Capsules [UPDATED WARNING 2026] Slim Tide Uncovering the Real Truth Behind the Trending Weight Loss Supplement | Web3Wire")
